Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Capital Expenditures (2024)

Pyxis Oncology (PYXS) has disclosed Capital Expenditures for 1 consecutive years, with $237000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Capital Expenditures changed N/A to $237000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $237000.0, a N/A change, with the full-year FY2024 number at $237000.0, down 96.48% from a year prior.
  • Capital Expenditures was $237000.0 for Q1 2024 at Pyxis Oncology.
  • In the past five years, Capital Expenditures ranged from a high of $237000.0 in Q1 2024 to a low of $237000.0 in Q1 2024.